Molecular Characterization of MSI-H Colorectal Cancer by MLHI Promoter Methylation, Immunohistochemistry, and Mismatch Repair Germline Mutation Screening
- 1 November 2008
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 17 (11) , 3208-3215
- https://doi.org/10.1158/1055-9965.epi-08-0512
Abstract
Microsatellite instability (MSI) occurs in 10% to 20% of colorectal cancers (CRC) and has been attributed to both MLH1 promoter hypermethylation and germline mutation in the mismatch repair (MMR) genes. We present results from a large population- and clinic-based study of MLH1 methylation, immunohistochemistry, and MMR germline mutations that enabled us to (a) estimate the prevalence of MMR germline mutations and MLH1 methylation among MSI-H cases and help us understand if all MSI-H CRC is explained by these mechanisms and (b) estimate the associations between MLH1 methylation and sex, age, and tumor location within the colon. MLH1 methylation was measured in 1,061 population-based and 172 clinic-based cases of CRC. Overall, we observed MLH1 methylation in 60% of population-based MSI-H cases and in 13% of clinic-based MSI-H cases. Within the population-based cases with MMR mutation screening and conclusive immunohistochemistry results, we identified a molecular event in MMR in 91% of MSI-H cases: 54% had MLH1 methylation, 14% had a germline mutation in a MMR gene, and 23% had immunohistochemistry evidence for loss of a MMR protein. We observed a striking age difference, with the prevalence of a MMR germline mutation more than 4-fold lower and the prevalence of MLH1 methylation more than 4-fold higher in cases diagnosed after the age of 50 years than in cases diagnosed before that age. We also determined that female sex is an independent predictor of MLH1 methylation within the MSI-H subgroup. These results reinforce the importance of distinguishing between the underlying causes of MSI in studies of etiology and prognosis. (Cancer Epidemiol Biomarkers Prev 2008;17(11):3208–15)Keywords
This publication has 42 references indexed in Scilit:
- The Clinical Phenotype of Lynch Syndrome Due to Germ-Line PMS2 MutationsGastroenterology, 2008
- Left‐Sided microsatellite unstable colorectal cancers show less frequent methylation of hMLH1 and CpG island methylator phenotype than right‐sided onesJournal of Surgical Oncology, 2007
- MLH1 -93G>A Promoter Polymorphism and the Risk of Microsatellite-Unstable Colorectal CancerJNCI Journal of the National Cancer Institute, 2007
- CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancerNature Genetics, 2006
- A Gene Expression Signature of Genetic Instability in Colon CancerCancer Research, 2005
- Isolated Loss of PMS2 Expression in Colorectal Cancers: Frequency, Patient Age, and Familial AggregationClinical Cancer Research, 2005
- Evaluation of a Large, Population-Based Sample Supports a CpG Island Methylator Phenotype in Colon CancerGastroenterology, 2005
- Densely methylated MLH1 promoter correlates with decreased mRNA expression in sporadic colorectal cancersGenes, Chromosomes and Cancer, 2002
- The Frequency of Hereditary Defective Mismatch Repair in a Prospective Series of Unselected Colorectal CarcinomasAmerican Journal of Human Genetics, 2001
- Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinomaProceedings of the National Academy of Sciences, 1998